Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients

Background: The American Thyroid Association (ATA) guidelines risk stratify Brafv600e mutated multifocal papillary thyroid microcarcinoma (BMPTMC) into different recurrence risk groups by the extent of extrathyroidal extension (ETE). These findings and modifications for BMPTMC need to be verified in...

Full description

Bibliographic Details
Main Authors: Shuai Xue, Li Zhang, Peisong Wang, Jia Liu, Yue Yin, Meishan Jin, Liang Guo, Yuhua Zhou, Guang Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00407/full
id doaj-d967f9ab4baf4a43bea93c30ef60c3a9
record_format Article
spelling doaj-d967f9ab4baf4a43bea93c30ef60c3a92020-11-25T02:20:47ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922019-06-011010.3389/fendo.2019.00407467352Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese PatientsShuai Xue0Li Zhang1Peisong Wang2Jia Liu3Yue Yin4Meishan Jin5Liang Guo6Yuhua Zhou7Guang Chen8Department of Thyroid Surgery, The 1st Hospital of Jilin University, Changchun, ChinaDepartment of Nephrology, The 1st Hospital of Jilin University, Changchun, ChinaDepartment of Thyroid Surgery, The 1st Hospital of Jilin University, Changchun, ChinaDepartment of Thyroid Surgery, The 1st Hospital of Jilin University, Changchun, ChinaDepartment of Thyroid Surgery, The 1st Hospital of Jilin University, Changchun, ChinaDepartment of Pathology, The 1st Hospital of Jilin University, Changchun, ChinaDepartment of Pathology, The 1st Hospital of Jilin University, Changchun, ChinaDepartment of Pathology, The 1st Hospital of Jilin University, Changchun, ChinaDepartment of Thyroid Surgery, The 1st Hospital of Jilin University, Changchun, ChinaBackground: The American Thyroid Association (ATA) guidelines risk stratify Brafv600e mutated multifocal papillary thyroid microcarcinoma (BMPTMC) into different recurrence risk groups by the extent of extrathyroidal extension (ETE). These findings and modifications for BMPTMC need to be verified in additional studies.Methods: A retrospective cohort study was conducted in BMPTMC patients who underwent total thyroidectomy (TT) and central lymph node dissection (CLND) from 2008 to 2013. Overall, 1,207 patients were included, and predictive factors were identified by univariate and multivariate analysis over a mean 7.5-year follow up.Results: BMPTMC with ETE to capsule shows the same recurrence rate (3.8%) with intrathyroidal BMPTMC. Moreover, BMPTMC with ETE only to strap muscle, which belongs to high-risk group according to ATA guideline, shows relatively lower recurrence rate (13.3%) compared with some intermediate risk categories such as cN1 and >5 pN1. Multivariate analysis using a Cox proportional hazards regression model shows that total tumor diameter (TTD) is associated with significantly higher recurrence for BMPTMC with or without other risk factors (Hazard Ratio (HRO) = 9.86 [95%CI 5.35–18.20], p = 0.00; HRO = 2.32 [95%CI 1.12–4.85], p = 0.02; respectively), while Hashimoto thyroiditis (HT) is found to be protective against the recurrence (HRO = 0.51 [95%CI 0.33–0.79], p = 0.00; HRO = 0.47 [95%CI 0.25–0.89], p = 0.02; respectively).Conclusions: Taken together, capsular ETE and gross ETE to the strap muscles did not have the expected significant influence on recurrence for Chinese BMPTMC patients who underwent TT and CLND. Rather than the extent of ETE, TTD and the lack of HT were identified as predictors for recurrence among BMPTMC with or without other risk factors (vascular invasion, cN1, pN1>5, pN1>3 cm).https://www.frontiersin.org/article/10.3389/fendo.2019.00407/fullrisk stratificationrecurrencepapillary thyroid microcarcinomamultifocalityBrafV600E
collection DOAJ
language English
format Article
sources DOAJ
author Shuai Xue
Li Zhang
Peisong Wang
Jia Liu
Yue Yin
Meishan Jin
Liang Guo
Yuhua Zhou
Guang Chen
spellingShingle Shuai Xue
Li Zhang
Peisong Wang
Jia Liu
Yue Yin
Meishan Jin
Liang Guo
Yuhua Zhou
Guang Chen
Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients
Frontiers in Endocrinology
risk stratification
recurrence
papillary thyroid microcarcinoma
multifocality
BrafV600E
author_facet Shuai Xue
Li Zhang
Peisong Wang
Jia Liu
Yue Yin
Meishan Jin
Liang Guo
Yuhua Zhou
Guang Chen
author_sort Shuai Xue
title Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients
title_short Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients
title_full Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients
title_fullStr Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients
title_full_unstemmed Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients
title_sort predictive factors of recurrence for multifocal papillary thyroid microcarcinoma with brafv600e mutation: a single center study of 1,207 chinese patients
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2019-06-01
description Background: The American Thyroid Association (ATA) guidelines risk stratify Brafv600e mutated multifocal papillary thyroid microcarcinoma (BMPTMC) into different recurrence risk groups by the extent of extrathyroidal extension (ETE). These findings and modifications for BMPTMC need to be verified in additional studies.Methods: A retrospective cohort study was conducted in BMPTMC patients who underwent total thyroidectomy (TT) and central lymph node dissection (CLND) from 2008 to 2013. Overall, 1,207 patients were included, and predictive factors were identified by univariate and multivariate analysis over a mean 7.5-year follow up.Results: BMPTMC with ETE to capsule shows the same recurrence rate (3.8%) with intrathyroidal BMPTMC. Moreover, BMPTMC with ETE only to strap muscle, which belongs to high-risk group according to ATA guideline, shows relatively lower recurrence rate (13.3%) compared with some intermediate risk categories such as cN1 and >5 pN1. Multivariate analysis using a Cox proportional hazards regression model shows that total tumor diameter (TTD) is associated with significantly higher recurrence for BMPTMC with or without other risk factors (Hazard Ratio (HRO) = 9.86 [95%CI 5.35–18.20], p = 0.00; HRO = 2.32 [95%CI 1.12–4.85], p = 0.02; respectively), while Hashimoto thyroiditis (HT) is found to be protective against the recurrence (HRO = 0.51 [95%CI 0.33–0.79], p = 0.00; HRO = 0.47 [95%CI 0.25–0.89], p = 0.02; respectively).Conclusions: Taken together, capsular ETE and gross ETE to the strap muscles did not have the expected significant influence on recurrence for Chinese BMPTMC patients who underwent TT and CLND. Rather than the extent of ETE, TTD and the lack of HT were identified as predictors for recurrence among BMPTMC with or without other risk factors (vascular invasion, cN1, pN1>5, pN1>3 cm).
topic risk stratification
recurrence
papillary thyroid microcarcinoma
multifocality
BrafV600E
url https://www.frontiersin.org/article/10.3389/fendo.2019.00407/full
work_keys_str_mv AT shuaixue predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
AT lizhang predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
AT peisongwang predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
AT jialiu predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
AT yueyin predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
AT meishanjin predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
AT liangguo predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
AT yuhuazhou predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
AT guangchen predictivefactorsofrecurrenceformultifocalpapillarythyroidmicrocarcinomawithbrafv600emutationasinglecenterstudyof1207chinesepatients
_version_ 1724869779853934592